| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.56e-08 | 11 | 61 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.66e-06 | 32 | 61 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.09e-06 | 42 | 61 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 CREBBP ZNF774 | 3.85e-04 | 1459 | 61 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.72e-04 | 130 | 61 | 4 | GO:0005200 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 1.21e-03 | 17 | 61 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF668 ZNF536 ZNF628 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF774 | 1.23e-03 | 1244 | 61 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF668 ZNF536 ZNF628 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF774 | 1.46e-03 | 1271 | 61 | 11 | GO:0000987 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.92e-06 | 31 | 60 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.17e-06 | 35 | 60 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.90e-06 | 482 | 60 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.44e-05 | 412 | 60 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 3.95e-05 | 131 | 60 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.22e-05 | 445 | 60 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.45e-05 | 347 | 60 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | VEGFC SFRP2 FBN2 ATXN7 ZNF423 PCSK6 LRP2 PXN CHRD IDE CREBBP AKAP7 | 1.32e-04 | 1186 | 60 | 12 | GO:0007167 |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.69e-04 | 197 | 60 | 5 | GO:0030509 | |
| GeneOntologyBiologicalProcess | neuron projection development | POTEE SFRP2 OTOGL POTEF ZNF335 DPYSL5 LRP2 MACF1 POTEKP POTEI CREBBP DICER1 | 2.79e-04 | 1285 | 60 | 12 | GO:0031175 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.90e-07 | 94 | 60 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.28e-07 | 104 | 60 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.97e-07 | 109 | 60 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.08e-06 | 32 | 60 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.08e-06 | 32 | 60 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 8.37e-06 | 45 | 60 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | POTEE KBTBD6 ATXN7 POTEF POTEKP IDE POTEI CREBBP DICER1 KBTBD7 | 4.10e-04 | 972 | 60 | 10 | GO:0140535 |
| GeneOntologyCellularComponent | actin filament | 8.22e-04 | 146 | 60 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | transferase complex | 1.61e-03 | 963 | 60 | 9 | GO:1990234 | |
| Domain | - | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 1.98e-09 | 679 | 59 | 15 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF668 ZNF536 ZNF628 ZNF684 ATXN7 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 2.01e-09 | 796 | 59 | 16 | IPR015880 |
| Domain | Znf_C2H2 | ZNF668 ZNF536 ZNF628 ZNF684 ATXN7 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 2.36e-09 | 805 | 59 | 16 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF668 ZNF536 ZNF628 ZNF684 ATXN7 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 2.49e-09 | 808 | 59 | 16 | SM00355 |
| Domain | zf-C2H2 | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 2.62e-09 | 693 | 59 | 15 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 2.67e-09 | 694 | 59 | 15 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 1.18e-08 | 775 | 59 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 1.22e-08 | 777 | 59 | 15 | PS00028 |
| Domain | Actin_CS | 1.63e-05 | 16 | 59 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.97e-05 | 17 | 59 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.36e-05 | 18 | 59 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.80e-05 | 19 | 59 | 3 | PS01132 | |
| Domain | cEGF | 7.39e-05 | 26 | 59 | 3 | IPR026823 | |
| Domain | cEGF | 7.39e-05 | 26 | 59 | 3 | PF12662 | |
| Domain | Actin | 1.26e-04 | 31 | 59 | 3 | IPR004000 | |
| Domain | Actin | 1.26e-04 | 31 | 59 | 3 | PF00022 | |
| Domain | ACTIN | 1.26e-04 | 31 | 59 | 3 | SM00268 | |
| Domain | EGF | 8.70e-04 | 235 | 59 | 5 | SM00181 | |
| Domain | EGF-like_dom | 1.13e-03 | 249 | 59 | 5 | IPR000742 | |
| Domain | Disintegrin_CS | 1.14e-03 | 16 | 59 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.45e-03 | 18 | 59 | 2 | PF08516 | |
| Domain | Prtase_inh_Kunz-CS | 1.45e-03 | 18 | 59 | 2 | IPR020901 | |
| Domain | KU | 1.45e-03 | 18 | 59 | 2 | SM00131 | |
| Domain | Growth_fac_rcpt_ | 1.49e-03 | 156 | 59 | 4 | IPR009030 | |
| Domain | BPTI_KUNITZ_2 | 1.62e-03 | 19 | 59 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.62e-03 | 19 | 59 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.62e-03 | 19 | 59 | 2 | PS00280 | |
| Domain | - | 1.80e-03 | 20 | 59 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 1.98e-03 | 21 | 59 | 2 | PF00200 | |
| Domain | DISIN | 1.98e-03 | 21 | 59 | 2 | SM00050 | |
| Domain | Kunitz_BPTI | 2.38e-03 | 23 | 59 | 2 | IPR002223 | |
| Domain | EGF_CA | 2.54e-03 | 86 | 59 | 3 | PF07645 | |
| Domain | - | 2.87e-03 | 449 | 59 | 6 | 3.30.40.10 | |
| Domain | zf-C2H2_6 | 3.10e-03 | 314 | 59 | 5 | PF13912 | |
| Domain | Znf_RING/FYVE/PHD | 3.20e-03 | 459 | 59 | 6 | IPR013083 | |
| Domain | ACR | 3.27e-03 | 27 | 59 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 3.27e-03 | 27 | 59 | 2 | IPR006586 | |
| Domain | EGF_Ca-bd_CS | 3.58e-03 | 97 | 59 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.79e-03 | 99 | 59 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.90e-03 | 100 | 59 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.59e-03 | 106 | 59 | 3 | IPR000152 | |
| Domain | EGF_3 | 6.47e-03 | 235 | 59 | 4 | PS50026 | |
| Domain | Peptidase_M12B_N | 6.74e-03 | 39 | 59 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.74e-03 | 39 | 59 | 2 | PF01562 | |
| Domain | EGF_CA | 6.77e-03 | 122 | 59 | 3 | SM00179 | |
| Domain | DISINTEGRIN_1 | 7.08e-03 | 40 | 59 | 2 | PS00427 | |
| Domain | LDLR_class-A_CS | 7.08e-03 | 40 | 59 | 2 | IPR023415 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.23e-08 | 15 | 62 | 4 | 16824795 | |
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 16364570 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8268913 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9782094 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 3.13e-06 | 2 | 62 | 2 | 19669888 | |
| Pubmed | Molecular, biochemical, and cellular characterization of epididymal ADAMs, ADAM7 and ADAM28. | 3.13e-06 | 2 | 62 | 2 | 15883027 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12393497 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 9.37e-06 | 3 | 62 | 2 | 26788497 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 9.37e-06 | 3 | 62 | 2 | 17101985 | |
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 9.37e-06 | 3 | 62 | 2 | 32572597 | |
| Pubmed | 2.63e-05 | 1116 | 62 | 10 | 31753913 | ||
| Pubmed | Mapping modifiers affecting muscularity of the myostatin mutant (Mstn(Cmpt-dl1Abc)) compact mouse. | 3.12e-05 | 5 | 62 | 2 | 14504233 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 14630787 | ||
| Pubmed | 3.16e-05 | 100 | 62 | 4 | 21800051 | ||
| Pubmed | Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. | 4.67e-05 | 6 | 62 | 2 | 19288010 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 33990333 | ||
| Pubmed | Aldo-keto reductase 1b7, a novel marker for renin cells, is regulated by cyclic AMP signaling. | 6.53e-05 | 7 | 62 | 2 | 26180185 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 17268172 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.32e-04 | 55 | 62 | 3 | 19468303 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 25684205 | ||
| Pubmed | 1.94e-04 | 674 | 62 | 7 | 37196079 | ||
| Pubmed | 2.64e-04 | 709 | 62 | 7 | 22988430 | ||
| Pubmed | Tbx18 regulates development of the epicardium and coronary vessels. | 2.81e-04 | 14 | 62 | 2 | 24016759 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 19703589 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 3.69e-04 | 16 | 62 | 2 | 17521568 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 4.85e-04 | 364 | 62 | 5 | 24778252 | |
| Pubmed | 5.14e-04 | 87 | 62 | 3 | 37495603 | ||
| Pubmed | PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis. | 5.24e-04 | 19 | 62 | 2 | 28049691 | |
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 5.24e-04 | 19 | 62 | 2 | 30385546 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.27e-04 | 588 | 62 | 6 | 38580884 | |
| Pubmed | 6.85e-04 | 96 | 62 | 3 | 23580065 | ||
| Pubmed | Genome-wide association with select biomarker traits in the Framingham Heart Study. | 7.72e-04 | 23 | 62 | 2 | 17903293 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 8.08e-04 | 233 | 62 | 4 | 32290105 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 8.41e-04 | 24 | 62 | 2 | 30190310 | |
| Pubmed | 8.41e-04 | 24 | 62 | 2 | 23552073 | ||
| Pubmed | 8.41e-04 | 24 | 62 | 2 | 31740596 | ||
| Pubmed | Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. | 8.41e-04 | 24 | 62 | 2 | 20573697 | |
| Pubmed | 9.88e-04 | 1442 | 62 | 9 | 35575683 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 31138536 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 19850029 | ||
| Pubmed | Conditionals by inversion provide a universal method for the generation of conditional alleles. | 1.07e-03 | 27 | 62 | 2 | 23918385 | |
| Pubmed | 1.15e-03 | 28 | 62 | 2 | 24880616 | ||
| Pubmed | Genome-wide association study of hematological and biochemical traits in a Japanese population. | 1.18e-03 | 116 | 62 | 3 | 20139978 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.41e-03 | 271 | 62 | 4 | 32433965 | |
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 1.50e-03 | 32 | 62 | 2 | 35813202 | |
| Pubmed | 1.69e-03 | 34 | 62 | 2 | 20708584 | ||
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.69e-03 | 34 | 62 | 2 | 25925205 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.76e-03 | 288 | 62 | 4 | 31501420 | |
| Interaction | GREM2 interactions | 4.97e-06 | 37 | 62 | 4 | int:GREM2 | |
| Interaction | EBF1 interactions | 1.83e-05 | 17 | 62 | 3 | int:EBF1 | |
| Interaction | ZFP41 interactions | 2.84e-05 | 57 | 62 | 4 | int:ZFP41 | |
| Interaction | GC interactions | 3.96e-05 | 62 | 62 | 4 | int:GC | |
| Interaction | ALX3 interactions | 4.10e-05 | 22 | 62 | 3 | int:ALX3 | |
| Interaction | IL17B interactions | 9.77e-05 | 78 | 62 | 4 | int:IL17B | |
| Interaction | TAFA3 interactions | 9.77e-05 | 78 | 62 | 4 | int:TAFA3 | |
| Cytoband | 2q21.1 | 1.21e-06 | 58 | 62 | 4 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 5.41e-05 | 151 | 62 | 4 | chr2q21 | |
| Cytoband | 8p21.2 | 5.28e-04 | 25 | 62 | 2 | 8p21.2 | |
| Cytoband | 2q11.1 | 6.63e-04 | 28 | 62 | 2 | 2q11.1 | |
| Cytoband | 13q14.11 | 1.29e-03 | 39 | 62 | 2 | 13q14.11 | |
| Cytoband | 20q13.12 | 3.02e-03 | 60 | 62 | 2 | 20q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF668 ZNF536 ZNF628 ZNF684 ZNF423 ZNF335 ZNF780B ZNF521 HIC2 ZNF784 ZNF692 ZNF688 ZXDA ZNF774 ZXDB | 5.14e-10 | 718 | 50 | 15 | 28 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.63e-08 | 13 | 50 | 4 | 685 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.52e-03 | 27 | 50 | 2 | 47 | |
| Coexpression | GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN | 4.03e-07 | 199 | 61 | 7 | M8065 | |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 6.77e-06 | 198 | 61 | 6 | M4247 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K0 | 2.82e-05 | 64 | 58 | 4 | facebase_RNAseq_e8.5_FloorPlate_2500_K0 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.69e-06 | 195 | 62 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.89e-06 | 196 | 62 | 5 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.08e-06 | 197 | 62 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 150 | 62 | 4 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.32e-05 | 160 | 62 | 4 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.32e-05 | 160 | 62 | 4 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.32e-05 | 160 | 62 | 4 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.44e-05 | 166 | 62 | 4 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.44e-05 | 166 | 62 | 4 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-05 | 169 | 62 | 4 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-05 | 169 | 62 | 4 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.04e-05 | 169 | 62 | 4 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.33e-05 | 63 | 62 | 3 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 9.68e-05 | 172 | 62 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.68e-05 | 172 | 62 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 176 | 62 | 4 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 179 | 62 | 4 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 180 | 62 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-04 | 180 | 62 | 4 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-04 | 180 | 62 | 4 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 183 | 62 | 4 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 183 | 62 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 186 | 62 | 4 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 71 | 62 | 3 | 879551882097cfaa4eccf11cb07f3bae68c777c3 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 71 | 62 | 3 | 8557be86709925cf19125e44c909133fd5adcb62 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 62 | 4 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 188 | 62 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 189 | 62 | 4 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 190 | 62 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 190 | 62 | 4 | 92fdfed12061ee9f6c7171cf8a7f3344921f2d40 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 190 | 62 | 4 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 191 | 62 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 193 | 62 | 4 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 194 | 62 | 4 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 1.54e-04 | 194 | 62 | 4 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 194 | 62 | 4 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-04 | 196 | 62 | 4 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.60e-04 | 196 | 62 | 4 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 198 | 62 | 4 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | 2e6630eab77b12a6059682ab5ba465f38e469102 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 198 | 62 | 4 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-04 | 200 | 62 | 4 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-04 | 200 | 62 | 4 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 82 | 62 | 3 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 82 | 62 | 3 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 82 | 62 | 3 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.69e-04 | 90 | 62 | 3 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| Disease | Stage IV Skin Melanoma | 6.36e-05 | 7 | 52 | 2 | C1321872 | |
| Disease | chin morphology measurement | 2.60e-04 | 70 | 52 | 3 | EFO_0007842 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 5.11e-04 | 19 | 52 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | cortical surface area change measurement, age at assessment | 5.11e-04 | 19 | 52 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 6.36e-04 | 222 | 52 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.69e-04 | 225 | 52 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.38e-04 | 239 | 52 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | ocular sarcoidosis | 1.14e-03 | 116 | 52 | 3 | EFO_0010723 | |
| Disease | Papillary Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.51e-03 | 128 | 52 | 3 | C1266044 | |
| Disease | Developmental delay (disorder) | 1.95e-03 | 37 | 52 | 2 | C0424605 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.28e-03 | 148 | 52 | 3 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APFRSKEPCMAEEVC | 151 | Q6ZRH7 | |
| FPFCGCDKEDDILPM | 546 | Q5FYA8 | |
| AGMVCRPAKDECDLP | 461 | Q9UKQ2 | |
| RPAKDECDFPEMCTG | 461 | Q9H2U9 | |
| RCPEALFQPCFLGME | 256 | Q9BYX7 | |
| TCKVPPFVFFFMCCA | 146 | Q92685 | |
| MGQLCCFPFSRDEGK | 1 | O43687 | |
| EGFVCKFSFKGMCRP | 176 | Q9NPY3 | |
| DPEPFVDCKECGRKM | 1276 | Q92793 | |
| DSEYGCLKIPPRCMF | 1636 | Q9UPY3 | |
| RCPEALFQPCFLGME | 956 | A5A3E0 | |
| MEDPAECGAFSKPCF | 596 | Q8TEW8 | |
| PFKGCFHVPRCLAMC | 386 | P51606 | |
| SEAFCPRDCMVPVVF | 46 | Q15013 | |
| GPAKCRECEAFMVSG | 501 | Q9P107 | |
| KCVPACGEGFYPEEM | 876 | P29122 | |
| QGKCMPFFRAGFVCP | 271 | P22079 | |
| PPHEFKCDNGRCIEM | 3076 | P98164 | |
| CAKEMVIFFGHPRDP | 341 | Q8WVZ9 | |
| NGMKCVAGLCPRDFE | 81 | Q02509 | |
| MGLCREDMPIFGFCP | 126 | O15265 | |
| REIACGAQSEPFPCM | 3096 | Q9UPN3 | |
| MFAPKCGGCARAILE | 471 | P49023 | |
| RCPEALFQPCFLGME | 956 | Q6S8J3 | |
| MRPHEFCAEPKFICE | 76 | Q6ZSI9 | |
| MSAVVKPCGFPFGCL | 221 | Q9NXB9 | |
| REMDSCPVVGEFPCQ | 961 | P14735 | |
| PFFEGKCVELETGMC | 1226 | Q9Y4K1 | |
| ECIHPVPGKFRMDAC | 1011 | P35556 | |
| VFMCAEGTGKFCPLR | 451 | Q9BPU6 | |
| VCCGEDEIVYPRMPG | 11 | P0C7A2 | |
| CAKEMVIFFGHPRDP | 341 | Q86V97 | |
| LNCPKDVEMPDCGFR | 1501 | Q3ZCN5 | |
| VCEMPKETGPCLAYF | 76 | O95925 | |
| PGPDMFCLCGRIYKD | 356 | Q6ZN16 | |
| LGLKPFACDECGMRF | 556 | Q96JB3 | |
| VKDRCAPVMSAFGFP | 121 | Q96HF1 | |
| NCPACREPSPKMDFK | 51 | Q96BQ3 | |
| RCPEALFQPCFLGME | 956 | P0CG38 | |
| PFGVMRCVLCACEAP | 71 | Q9H2X0 | |
| DLVTCFCMKPFAGRP | 231 | Q86YI8 | |
| DRRFMCPVEGCGKSF | 481 | P98169 | |
| GERPFVCNDCGKAFM | 211 | Q5T5D7 | |
| CMPREVCIDVGKEFG | 131 | P49767 | |
| GEKPFLCPRCGRMFS | 276 | Q96K58 | |
| PCVLSCVMRGSPADF | 41 | O14924 | |
| FVMPRAKGHIFCEDC | 181 | Q7RTY8 | |
| VKHYMCPICGERFPS | 956 | Q96K83 | |
| ERPFKCPECGKGFRD | 316 | Q6NX45 | |
| MGEKPFECRECGKAF | 356 | Q9Y6R6 | |
| FPCPECGMRFKRKFA | 211 | P0C7X2 | |
| MKEKPTECPDCGRVF | 626 | O15090 | |
| DDRRFMCPVEGCGKS | 476 | P98168 | |
| AACPFPCMNDLKFPV | 1791 | Q86YA3 | |
| NCPACREPSPKMDFK | 51 | A6NCK2 | |
| DEATCMGFCAPKKIP | 141 | P48307 | |
| AKHYMCPICGERFPS | 956 | Q2M1K9 | |
| CKICAEAFPGRAEME | 1021 | Q9H4Z2 | |
| ELMPCDFPGCGRIFS | 326 | Q9BU19 | |
| PFTCPICGRGFVMAA | 621 | Q5EBL2 | |
| AVGKPFACRFCAKPF | 191 | Q8NCA9 | |
| CVMAECKRPPEAFGF | 371 | P41229 |